CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.
Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .
Livrables
List of partners identified in level of involvement.
ExpoMel Midterm recruitment report (s’ouvre dans une nouvelle fenêtre)Report when 50% of the study population is recruited. The report will include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.
Policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting 1 (s’ouvre dans une nouvelle fenêtre)Report on policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting
AI-MEL Midterm recruitment report (s’ouvre dans une nouvelle fenêtre)Report when 50% of the study population is recruited. The report will include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.
Report on molecular data collection of L/GCMN (s’ouvre dans une nouvelle fenêtre)Document detailing the results of molecular studies previously performed in L/GCMN
Standardized protocols and procedures for melanoma sub-classification (s’ouvre dans une nouvelle fenêtre)Document detailing the standardized protocols and procedures for melanoma sub-classification including staining, immunohistochemistry and molecular studies (FISH, NGS, others)
Immuno-Ped initiation package (s’ouvre dans une nouvelle fenêtre)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.
Standardized protocols for tumor tissue processing (s’ouvre dans une nouvelle fenêtre)Document detailing the standardized protocols for tumor tissue processing (inclusion, orientation of the sample, sectioning, etc)
Conclusions of common annual meeting of the ‘Understanding’ cluster 3 (s’ouvre dans une nouvelle fenêtre)Report on the conclusions of common annual meeting of the ‘Understanding’ cluster
Dissemination & communication plan 1 (s’ouvre dans une nouvelle fenêtre)Document describing the dissemination and communication plan
Policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting 3 (s’ouvre dans une nouvelle fenêtre)Report on policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting
Project Management Plan (s’ouvre dans une nouvelle fenêtre)Document describing the management plan for MELCAYA project
Plan for ethic-legal monitoring & ethical submissions 1 (s’ouvre dans une nouvelle fenêtre)Document detailing the plan for ethic-legal monitoring & ethical submissions
Common work plan for scientific collaboration under the ‘Understanding’ cluster (s’ouvre dans une nouvelle fenêtre)Report on the common work plan for scientific collaboration under the ‘Understanding’ cluster
NevustoMel initiation package (s’ouvre dans une nouvelle fenêtre)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.
Immuno-Ped Midterm recruitment report (s’ouvre dans une nouvelle fenêtre)Report when 50% of the study population is recruited. The report will include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.
Immuno-Ped II initiation package (s’ouvre dans une nouvelle fenêtre)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.
Patient engagement plan (s’ouvre dans une nouvelle fenêtre)Detailed plan for patient engagement
AI-MEL initiation package (s’ouvre dans une nouvelle fenêtre)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.AI-MEL study protocol will include information about how humans will maintain meaningful control over the decision-making process for the use of the prediction and diagnostic tool to be developed in the project.
Mol-Mel Midterm recruitment report (s’ouvre dans une nouvelle fenêtre)Report when 50% of the study population is recruited. The report will include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.
Plan for ethic-legal monitoring & ethical submissions 2 (s’ouvre dans une nouvelle fenêtre)Document detailing the plan for ethic-legal monitoring & ethical submissions
Conclusions of common annual meeting of the ‘Understanding’ cluster 1 (s’ouvre dans une nouvelle fenêtre)Report on the conclusions of common annual meeting of the ‘Understanding’ cluster
Dissemination & communication plan 2 (s’ouvre dans une nouvelle fenêtre)Document describing the dissemination and communication plan
Exploitation strategy (s’ouvre dans une nouvelle fenêtre)Document detailing the strategy for exploitation of the results
Precis-mel initiation package (s’ouvre dans une nouvelle fenêtre)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.The study protocol will include information about how humans will maintain meaningful control over the decision-making process for the use of the prediction and diagnostic tool to be developed in the project. No further deliverables will be required.
Policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting 2 (s’ouvre dans une nouvelle fenêtre)Report on policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting
NevustoMel Midterm recruitment report (s’ouvre dans une nouvelle fenêtre)Report when 50% of the study population is recruited. The report will include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.
Mid-term report on quality control (s’ouvre dans une nouvelle fenêtre)Document reporting quality issues identified and measures for correction.
Quality Assurance and Risk Management Plan (s’ouvre dans une nouvelle fenêtre)Document detailing the Quality Assurance and Risk Management Plan
ExpoMel initiation package (s’ouvre dans une nouvelle fenêtre)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.
Framework for assessing innovative HTs (s’ouvre dans une nouvelle fenêtre)Document describing the framework for assessing innovative Health technologies
Mol-Mel initiation package (s’ouvre dans une nouvelle fenêtre)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.
Conclusions of common annual meeting of the ‘Understanding’ cluster 2 (s’ouvre dans une nouvelle fenêtre)Report on the conclusions of common annual meeting of the ‘Understanding’ cluster
Video and/or common cluster brochure of the projects included in the Mission Cancer Cluster 'Understanding'.
Project Website (s’ouvre dans une nouvelle fenêtre)MELCAYA webpage with public and private domains
Online and media presence 1 (s’ouvre dans une nouvelle fenêtre)Document with the summary of all on line MELCAYA post, citations and interactions
Document detailing the Data Management PlanThe preparation of the Data Management Plan will include a common chapter onthe ‘Understanding’ cluster. The aim of the chapter is to addresscommonalities in data standards, data validation, data protection andfostering data exchange, in particular when it comes to sharing project datawith a future federated UNCAN.eu data platform. Therefore, interactions areenvisaged with the 4.UNCAN.eu (http://uncaninitiative.eu/) coordination andsupport action which is preparing a blueprint for UNCAN.eu
Data Management Plan 1 (s’ouvre dans une nouvelle fenêtre)Document detailing the Data Management PlanThe preparation of the Data Management Plan will include a common chapter onthe ‘Understanding’ cluster. The aim of the chapter is to addresscommonalities in data standards, data validation, data protection andfostering data exchange, in particular when it comes to sharing project datawith a future federated UNCAN.eu data platform. Therefore, interactions areenvisaged with the 4.UNCAN.eu (http://uncaninitiative.eu/) coordination andsupport action which is preparing a blueprint for UNCAN.eu.
Data Management Plan 2 (s’ouvre dans une nouvelle fenêtre)Document detailing the Data Management PlanThe preparation of the Data Management Plan will include a common chapter onthe ‘Understanding’ cluster. The aim of the chapter is to addresscommonalities in data standards, data validation, data protection andfostering data exchange, in particular when it comes to sharing project datawith a future federated UNCAN.eu data platform. Therefore, interactions areenvisaged with the 4.UNCAN.eu (http://uncaninitiative.eu/) coordination andsupport action which is preparing a blueprint for UNCAN.eu
Publications
Auteurs:
Pietro Refolo; Costanza Raimondi; Violeta Astratinei; Livio Battaglia; Josep M. Borràs; Paula Closa; Alessandra Lo Scalzo; Marco Marchetti; Sonia Muñoz-López; Laura Sampietro-Colom; Dario Sacchini
Publié dans:
Healthcare, 2025, ISSN 2227-9032
Éditeur:
MDPI
DOI:
10.3390/HEALTHCARE13070829
Auteurs:
Mario Mandalà, Andrea Ferrari, Ines B. Brecht, Karijn PM Suijkerbuijk, Linda Maschke, Diana Giannarelli, Alice Indini, Martina Ubaldi, Giulia Pecci, Victoria Atkinson, Hildur Helgadottir, Stefano Chiaravalli, Naima Benannoune, Caroline Robert, Pawel Teterycz, Piotr Rutkowski, Susana Puig, Gabriele Madonna, Rejin Kebudi, Shirly Grynberg, Lidia MRB Arantes, Ewa Bien, Malgorzata Krawczyk, Maria Debora De Pasquale, Miranda P. Dierselhuis, Daniela Massi, Georgina V. Long, Paolo Antonio Ascierto, Alexander M.M. Eggermont
Publié dans:
European Journal of Cancer, Numéro 211, 2024, ISSN 0959-8049
Éditeur:
Elsevier BV
DOI:
10.1016/J.EJCA.2024.114305
Auteurs:
Estefania Serra, Álvaro Abarzua-Araya, Ana Arance, Roberto Martin-Huertas, Francisco Aya, María Lourdes Olondo, Daniel Rizo-Potau, Josep Malvehy, Susana Puig, Cristina Carrera, Sebastian Podlipnik
Publié dans:
Cancers, 2024, ISSN 2072-6694
Éditeur:
MDPI
DOI:
10.3390/CANCERS16122272
Auteurs:
Indini, Alice; Didoné, Fabio; Massi, Daniela; Puig, Susana; Casadevall, Jordi Rubio; Bennett, Damien; Katalinic, Alexander; Sanvisens, Arantza; Ferrari, Andrea; Lasalvia, Paolo; Demuru, Elena; Ragusa, Rosalia; Mayer-da-Silva, Alexandra; Blum, Marcel; Mousavi, Mohsen; Kuehni, Claudia; Mihor, Ana; Mandalà, Mario; Trama, Annalisa
Publié dans:
European Journal of Cancer, 2024, ISSN 0959-8049
Éditeur:
Elsevier
DOI:
10.48620/77106
Auteurs:
E. Samaniego-González, S. Podlipnik, S. Ribero, E. Nagore, A. Boada, J. Cañueto, S. Paradela, B. de Unamuno, P. Rodríguez-Jiménez, S. Puig, J. Malvehy, C. Carrera, G. Roccuzzo, C. Requena, E. Manrique-Silva, N. Richarz, A. Ruiz-Villanueva, V. Traves, S. España-Fernández, R. Botella-Estrada, M.A. González-Morán, A. Tejera-Vaquerizo
Publié dans:
Actas Dermo-Sifiliográficas, Numéro 116, 2025, ISSN 0001-7310
Éditeur:
Elsevier BV
DOI:
10.1016/J.AD.2024.07.017
Auteurs:
Samaniego-González, E.; Podlipnik, S.; Ribero, S.; Nagore, E.; Boada, A.; Cañueto, J.; Paradela, S.; de Unamuno, B.; Rodríguez-Jiménez, P.; Puig, S.; Malvehy, J.; Carrera, C.; Roccuzzo, G.; Requena, C.; Manrique-Silva, E.; Richarz, N.; Ruiz-Villanueva, A.; Traves, V.; España-Fernández, S.; Botella-Estrada, R.; González-Morán, M. A.; Tejera-Vaquerizo, A.
Publié dans:
Actas Dermo-Sifiliográficas, 2025, ISSN 0001-5555
Éditeur:
Taylor & Francis
DOI:
10.1016/J.AD.2024.07.017
Auteurs:
Pietro Refolo; Costanza Raimondi; Livio Battaglia; Josep M. Borràs; Paula Closa; Alessandra Lo Scalzo; Marco Marchetti; Sonia Muñoz López; Joan Prades Perez; Laura Sampietro-Colom; Dario Sacchini
Publié dans:
Healthcare, 2025, ISSN 2227-9032
Éditeur:
MDPI
DOI:
10.3390/HEALTHCARE13030321
Auteurs:
Estefania Serra; Álvaro Abarzua-Araya; Ana Arance; Roberto Martin-Huertas; Francisco Aya; María Lourdes Olondo; Daniel Rizo-Potau; Josep Malvehy; Susana Puig; Cristina Carrera; Sebastian Podlipnik
Publié dans:
Cancers, 2024, ISSN 2072-6694
Éditeur:
MDPI
DOI:
10.3390/CANCERS16122272
Auteurs:
Elise Marechal, Patrice Quintana, Daniel Aldea, Grégoire Mondielli, Nathalie Bernard-Marissal, Mathias Moreno, Valérie Delague, Lauren A. Weiss, Anne Barlier, Heather C. Etchevers
Publié dans:
bioRxiv, 2024, ISSN 1531-6386
Éditeur:
bioRxiv
DOI:
10.1101/2024.04.24.590951
Auteurs:
J. Angel-Baldo, S. Podlipnik, A. Azón, A. Boada, A. Arrieta, J. Marcoval, C. López-Sánchez, M. Sàbat, S. Segura, D. Bodet, N. Curcó, D. Lopez-Castillo, J. Solà, M. Quintana-Codina, C. Baliu-Piqué, M. Just-Sarobé, S. Martín-Sala, J. Malvehy, S. Puig, C. Carrera, R.M. Marti, Clara Matas-Nadal, Xavier Soria, Sonia Gatius, Felip Vilardell, Inma Gil, Cristina Grau, Fani Martínez, Nelson Lobos, Oriol Yélamos, Joan Dalmau, Carlos González-Cruz, Helena Hilari, Paola Pasquali, Marc Sagristà, María Rosa Olivella-Garcés, Montserrat Bonfill-Ortí, Josep Ramón Ferreres, Ane Jaka, Ariadna Quer, Nina Richarz, Inés Zarzoso Muñoz, Emili Masferrer, Pedro Zaballos, Manel Formigon, Loida Galvany, Marta Alegre, Anna Sánchez-Puigdollers, Nerea Mohino-Farré
Publié dans:
Actas Dermo-Sifiliográficas, Numéro 116, 2025, ISSN 0001-7310
Éditeur:
Elsevier BV
DOI:
10.1016/J.AD.2024.10.060
Auteurs:
Daniel Aldea, Nicolas Macagno, Elise Marechal, Mathias Moreno, Pauline Romanet, Morgane Pertuit, Jérémy Garcia, Nathalie Degardin, Stéphanie Mallet, Isabelle James, Guillaume Captier, Anne Barlier, Heather C. Etchevers
Publié dans:
Journal of Investigative Dermatology, Numéro 145, 2025, ISSN 0022-202X
Éditeur:
Elsevier BV
DOI:
10.1016/J.JID.2024.10.595
Auteurs:
Dario Di Gangi, Roberta Gugliotta, Filippo Ugolini, Anna Szumera-Ciećkiewicz, Llucia Alos, Natalia Castrejón, Stephan Forchhammer, Barbara Valeri, Nicolas Macagno, Sule Ozturk Sari, Ozge Hurdogan, Sokol Sina, Sylvie Fraitag, Valerio Gaetano Vellone, Chiara Trambaiolo, Rita Alaggio, Sabrina Rossi, Giovanni Arcuri, Daniela Massi, Claudio Conti
Publié dans:
EJC Skin Cancer, Numéro 3, 2025, ISSN 2772-6118
Éditeur:
Elsevier BV
DOI:
10.1016/J.EJCSKN.2025.100742
Auteurs:
Baron, Roni; Haick, Hossam
Publié dans:
ACS Sensors, 2024, ISSN 2379-3708
Éditeur:
American Chemical Society (ACS)
DOI:
10.1021/ACSSENSORS.4C00636
Auteurs:
Alexandra Liebmann, Jakob Admard, Sorin Armeanu-Ebinger, Hannah Wild, Michael Abele, Axel Gschwind, Olga Seibel-Kelemen, Christian Seitz, Irina Bonzheim, Olaf Riess, German Demidov, Marc Sturm, Malou Schadeck, Michaela Pogoda, Ewa Bien, Malgorzata Krawczyk, Eva Jüttner, Thomas Mentzel, Maja Cesen, Elke Pfaff, Michal Kunc, Stephan Forchhammer, Andrea Forschner, Ulrike Leiter-Stöppke, Thomas K. Eigentler, Dominik T. Schneider, Christopher Schroeder, Stephan Ossowski, Ines B. Brecht
Publié dans:
eBioMedicine, Numéro 96, 2023, ISSN 2352-3964
Éditeur:
Elsevier BV
DOI:
10.1016/J.EBIOM.2023.104797
Auteurs:
Javier Gil-Lianes; Victoria Amat-Samaranch; Priscila Giavedoni; Antoni Vilaseca; Julián Córdoba Sánchez; Francesc Alamon-Reig; Paola Castillo; Adriana P. Garcia; Mariona Pascal; Cristina Carrera
Publié dans:
Acta Dermato-Venereologica, 2024, ISSN 1651-2057
Éditeur:
Medical Journals Sweden
DOI:
10.2340/ACTADV.V104.40719
Auteurs:
Àngel-Baldó, Joan; Segura Tigell, Sonia; Network of Melanoma Centers of Catalonia
Publié dans:
instname:Universitat Pompeu Fabra, 2025, ISSN 0001-7310
Éditeur:
Actas Dermo-Sifiliográficas
DOI:
10.1016/J.AD.2024.10.060
Auteurs:
Alexandra Liebmann; Jakob Admard; Sorin Armeanu-Ebinger; Hannah Wild; Michael Abele; Axel Gschwind; Olga Seibel-Kelemen; Christian Seitz; Irina Bonzheim; Olaf Riess; German Demidov; Marc Sturm; Malou Schadeck; Michaela Pogoda; Ewa Bien; Malgorzata Krawczyk; Eva Jüttner; Thomas Mentzel; Maja Cesen; Elke Pfaff; Michal Kunc; Stephan Forchhammer; Andrea Forschner; Ulrike Leiter-Stöppke; Thomas K. Eigentler; Dominik T. Schneider; Christopher Schroeder; Stephan Ossowski; Ines B. Brecht
Publié dans:
eBioMedicine, Numéro Elsevier, 2023, ISSN 2352-3964
Éditeur:
Elsevier BV
DOI:
10.1016/J.EBIOM.2023.104797
Auteurs:
Mandalà, Mario; Ferrari, Andrea; Brecht, Ines B.; Suijkerbuijk, Karijn PM; Maschke, Linda; Giannarelli, Diana; Indini, Alice; Ubaldi, Martina; Pecci, Giulia; Atkinson, Victoria; Helgadottir, Hildur; Chiaravalli, Stefano; Benannoune, Naima; Robert, Caroline; Teterycz, Pawel; Rutkowski, Piotr; Puig, Susana; Madonna, Gabriele; Kebudi, Rejin; Grynberg, Shirly; Arantes, Lidia MRB; Bien, Ewa; Krawczyk, Malgorzata; Pasquale, Maria Debora De; Dierselhuis, Miranda P.; Massi, Daniela; Long, Georgina V.; Ascierto, Paolo Antonio; Eggermont, Alexander M. M.
Publié dans:
European Journal of Cancer, 2024, ISSN 0959-8049
Éditeur:
Pergamon Press Ltd.
DOI:
10.1016/J.EJCA.2024.114305
Auteurs:
Alice Indini, Fabio Didoné, Daniela Massi, Susana Puig, Jordi Rubio Casadevall, Damien Bennett, Alexander Katalinic, Arantza Sanvisens, Andrea Ferrari, Paolo Lasalvia, Elena Demuru, Rosalia Ragusa, Alexandra Mayer-da-Silva, Marcel Blum, Mohsen Mousavi, Claudia Kuehni, Ana Mihor, Mario Mandalà, Annalisa Trama
Publié dans:
European Journal of Cancer, Numéro 213, 2024, ISSN 0959-8049
Éditeur:
Elsevier BV
DOI:
10.1016/J.EJCA.2024.115079
Auteurs:
Heather C. Etchevers
Publié dans:
Pigment Cell and Melanoma Research, 2025
Éditeur:
Wiley
DOI:
10.1111/PCMR.70045
Auteurs:
Daniel Aldea, Israa Fakih, Nicolas Macagno, Mathias Moreno, Anne Barlier, Heather C. Etchevers
Publié dans:
Pigment Cell and Melanoma Research, 2025
Éditeur:
Wiley
DOI:
10.1111/PCMR.70045
Recherche de données OpenAIRE...
Une erreur s’est produite lors de la recherche de données OpenAIRE
Aucun résultat disponible